Indications for TUDORZA PRESSAIR:
Maintenance treatment of patients with COPD.
400mcg twice daily (approx. 12hrs apart).
TUDORZA PRESSAIR Contraindications:
Milk protein sensitivity.
TUDORZA PRESSAIR Warnings/Precautions:
Not for initial treatment of acute episodes of bronchospasm. Narrow-angle glaucoma. Urinary retention. Discontinue immediately if hypersensitivity reactions occur; consider alternative therapy. Pregnancy. Nursing mothers.
TUDORZA PRESSAIR Classification:
TUDORZA PRESSAIR Interactions:
Avoid concomitant other anticholinergic agents.
Headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis; paradoxical bronchospasm (discontinue if occurs).
Generic Drug Availability:
Dry powder inhaler—60 doses